Remove 2025 Remove Dosage Remove Pharmaceutical Manufacturing
article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The WuXi STA Middletown facility is expected to begin operations in 2025.

article thumbnail

India and the United States manufacture most finished medicines for the U.S. market

Quality Matters

India and the United States manufacture most finished medicines for the U.S. market This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of finished dose forms. For a discussion on API manufacturing, see here.

Dosage 59